authors
- Antonia, SJ
- Gettinger, S
- Goldman, J
- Chow, LQ
- Juergens, Rosalyn
- Borghaei, H
- Brahmer, JR
- Shen, Y
- Harbison, C
- Chen, AC
- Ready, NE
- Rizvi, NA
Safety and Efficacy of First-Line Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) and Ipilimumab in Non-Small Cell Lung Cancer (NSCLC)
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- November 2014
has subject area
- 0299 Other Physical Sciences (FoR)
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)